The role of the DNA damage response protein kinase ataxia telangiectasia and Rad-3-related (ATR) in the cellular response to DNA damage during the replicative phase of the cell cycle has been extensively studied. However, little is known about ATR kinase function in cells that are not actively replicating DNA and which constitute most cells in the human body. Using small-molecule inhibitors of ATR kinase and overexpression of a kinase-inactive form of the enzyme, I show here that ATR promotes cell death in non-replicating/non-cycling cultured human cells exposed to N-acetoxy-2-acetylaminofluorene (NA-AAF), which generates bulky DNA adducts that block RNA polymerase movement. Immunoblot analyses of soluble protein extracts revealed that ATR and other cellular proteins containing SQ motifs become rapidly and robustly phosphorylated in non-cycling cells exposed to NA-AAF in a manner largely dependent on ATR kinase activity but independent of the essential nucleotide excision repair factor XPA. Although the topoisomerase I inhibitor camptothecin also activated ATR in noncycling cells, other transcription inhibitors that do not directly damage DNA failed to do so. Interestingly, genetic and pharmacological inhibition of the XPB subunit of transcription factor IIH (TFIIH) prevented the accumulation of the single-stranded DNA binding protein RPA on damaged chromatin and severely abrogated ATR signaling in response to NA-AAF and camptothecin. Together, these results reveal a previously unknown role for TFIIH in ATR kinase activation in non-replicating, noncycling cells.As one of the major DNA damage response signaling kinases in mammalian cells, the ATR 1 (ataxia telangiectasia and Rad3-related) kinase is primarily thought to respond to DNA polymerase stalling and uncoupling from DNA helicase activity as a result of template lesions or deoxyribonucleotide (dNTP) shortage (1-3). These replicative stress events are characterized by regions of single-stranded DNA (ssDNA) and a junction of ssDNA and dsDNA (5'-primertemplate junction), which together serve to recruit ATR and accessory proteins to ultimately activate ATR kinase signaling (2, 4). The functional outcomes of ATR activation in response to replication stress generally involve processes that ultimately promote cell survival, such as replication fork stabilization, cell cycle delay, inhibition of replication origin firing, DNA repair, and homologous recombination (2,5,6).These pro-survival functions of ATR in cells containing replication stress likely limit the therapeutic efficacy of anti-cancer drugs that damage DNA, and thus small molecule inhibitors of the ATR kinase are being developed as adjuvants in chemotherapy regimens (7-10).
ATR kinase activation in non-cycling cellsPreliminary studies using mouse models of tumor progression have indeed suggested that ATR kinase inhibition can exacerbate the antiproliferative effects of radiation and cisplatin to more effectively slow tumor growth and shrink tumor volume (11,12).However, the majority of cells in ...